Navigation Links
DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
Date:3/28/2013

New York, NY (PRWEB) March 28, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients taking the blood thinner Pradaxa. Researchers presented the American College of Cardiology with a new study this month warning of Pradaxa bleeding risks***, as the number of injury claims continues to grow****.

DrugRisks was designed to reduce the danger of side effects from popular prescription drugs by providing patients with the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide whether they need legal advice.

Information on the resource site shows health experts have disagreed about whether those taking Pradaxa to prevent strokes in atrial fibrillation face higher risks for internal bleeding. The FDA has updated its information to state the drug is as safe as warfarin*.

However, the Institute for Safe Medication Practices recently ranked blood thinners like Pradaxa among the most dangerous drugs available. They also cautioned that patients with bleeding from Pradaxa were nearly 5 times as likely to die than those with bleeding from warfarin**.

Now, DrugRisks has added information showing researchers from the University of Illinois at Chicago presented a study to the American College of Cardiology this month warning that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Due to the number of patients who have filed a Pradaxa lawsuit over allegations of internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

DrugRisks has also reviewed the latest information from the federal judicial panel on multidistrict litigation, which shows the number of lawsuits alleging serious or fatal internal bleeding has grown from 170 on January 14th to 260 as of March 5, 2013, an increase of over 50%.****

Those affected by internal bleeding after taking Pradaxa are encouraged to speak with a lawyer about their legal options. Since federal drug injury cases can be very specialized, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_by_District-March-5-2013.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-side-effects/litigation-lawsuit/prweb10579374.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. Approval of Safer Alternative to Pradaxa Delayed by FDA
3. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
4. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
5. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
6. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
7. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
8. DrugRisk Announces New Pradaxa Health Warning From Australia
9. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
10. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
11. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Chicago, Illinois (PRWEB) , ... February 05, 2016 ... ... advisors and independent PROSHRED franchises from across the country gathered at the La ... to recognize top performers. PROSHRED Chicago was named the year’s most outstanding ...
(Date:2/5/2016)... ... 05, 2016 , ... Boar’s Head Brand®, one of the nation’s leading providers ... Game. Take the stress out of your party preparation – follow these easy, yet ... stage of the game. , “The key to hosting a successful game-day party is ...
(Date:2/5/2016)... ... 05, 2016 , ... Stuart Bentkover, MD, FACS is thrilled to ... the most effective tattoo removal today, Dr. Bentkover is the only doctor in Central ... the PicoSure has been approved by the Food and Drug Administration (FDA) as a ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Health and ... more relevant to individuals in the event they are experiencing an illness. Migraines are ... Those Americans that are afflicted with migraines would not wish the pain on their ...
(Date:2/5/2016)... ... 2016 , ... KICVentures ( http://www.kicventures.com ) announced today that ... York City on Thursday, January 21, 2016. Kingsley R. Chin, the CEO ... the varsity Columbia soccer program) spoke at the event, offering professional insight based ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Calif. , Feb. 5, 2016  Syneron ... global aesthetic device company, announced today that ... Candela North America, is scheduled to participate in ... Healthcare Conference on February 11, 2016 in ... will allow institutional investors to meet with the ...
(Date:2/5/2016)... 5, 2016  Patients in Alabama ... (HIFU) therapy no longer have to travel out of state. ... with Urology Centers of Alabama to provide a ... for qualifying patients. Alabama ... treatment of prostate cancer using many different modalities. They are ...
(Date:2/5/2016)... 5, 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ... CEO, will be presenting at Source Capital Group,s 2016 Disruptive ... at 2:15 p.m. ET on Wednesday, February 10, ... discussion taking place at 3:15 p.m. ET. http://www.aethlonmedical.com ... hour after the conclusion of the live event. The panel ...
Breaking Medicine Technology: